David Baker - President & CEO @ GRI Bio (Reverse Merger With Vallon Pharmaceuticals)

Overview

Number of Founded Organizations

CB Rank (Person)

David Baker is the President & CEO of Vallon Pharmaceuticals. He attended Duke University - The Fuqua School of Business.

Number of Current Jobs

Number of Past Jobs

is the

President & CEO

. Additionally,

has had

past job as the

Interim CEO

Organization Name	Title At Company	Start Date	End Date
Alcobra Pharmaceuticals	Interim CEO	Jun 2017	Nov 2017

Hub Name	CB Rank (Hub)
Acquired Pennsylvania Companies	2,217
Acquired Philadelphia Companies	45,341
Closed Greater Philadelphia Area Companies	17,176
Closed Northeastern US Pharmaceutical Companies	21,731
Closed Pennsylvania Companies	9,423
Philadelphia Companies that Exited	44,059
Acquired Biopharma Companies	16,638
Closed Biopharma Companies	37,111
Acquired Greater Philadelphia Area Companies	4,639
Closed United States Pharmaceutical Companies	10,249